Michael Geffner, Chief Medical Officer at Immunovant, Inc. (IMVT), sold 6,378 shares at $29.53 ($188K) on 2024-10-23, disclosed to the SEC on 2024-10-25.
Open-market sale of $188k IMVT by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.53 | 3,189 | $94K | 50.0% |
| 2 | $29.53 | 3,189 | $94K | 50.0% |
| Total | $29.53 avg | 6,378 | $188K | 100% |
| Filing → |
| IMVT | SELL | 2025-07-25 | $43K | — | Filing → |
| IMVT | SELL | 2025-07-11 | $20K | — | Filing → |
| IMVT | SELL | 2025-04-25 | $35K | — | Filing → |